Clorox (NYSE:CLX) Releases FY 2025 Earnings Guidance

Clorox (NYSE:CLX) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share guidance of 6.950-7.350 for the period, compared to the consensus earnings per share estimate of 6.870. The company issued revenue guidance of $7.0 billion-$7.0 billion, compared to the consensus revenue estimate of $7.1 billion.

Clorox Stock Down 1.0 %

NYSE:CLX traded down $1.41 during mid-day trading on Wednesday, hitting $146.80. The company had a trading volume of 749,984 shares, compared to its average volume of 1,274,227. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37. The business has a fifty day simple moving average of $162.25 and a 200-day simple moving average of $158.76. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $18.17 billion, a price-to-earnings ratio of 51.16, a PEG ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same quarter last year, the firm posted $2.16 EPS. Equities analysts forecast that Clorox will post 6.86 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.32%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Analysts Set New Price Targets

A number of equities analysts have commented on CLX shares. DA Davidson cut their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday. Evercore ISI boosted their price target on Clorox from $145.00 to $155.00 in a research note on Tuesday. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Barclays lifted their price objective on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday. Finally, JPMorgan Chase & Co. increased their target price on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.